DMD and diabetes mellitus: In our study, we verified the effect of another iron chelator—DFO, as well as pioglitazone, the drug stabilizing the mitoNEET protein, and commonly used to treat diabetes.14 Our results demonstrated that treatment of DMD hiPSC-CM with DFO and pioglitazone decreased the ROS level and mitochondrial ROS production, respectively.